💛 A quick favor, if you've got a second.
We're really happy that you chose to read one of our stories and sincerely hope you'll stick around to read more. We took our paywall down — for now — but that won't last forever, and when the gate goes back up, we'd love for you to already be on the inside.
It's free. So please enter your email here and don't forget to like and follow us on all of your favorite Social Media platforms!
Unitree, a leading Chinese humanoid robotics manufacturer, experienced dramatic gains during its Wednesday trading debut on Shanghai’s STAR market, with shares climbing as much as 629% before settling nearly 500% higher by midday. The Hangzhou-based company, established in 2016 by entrepreneur Wang Xingxing, raised approximately 6.1 billion yuan ($904 million) through the offering, pricing shares at 150.80 yuan ($22.36) each.
The robust market reception underscores investor confidence in China’s technological trajectory, particularly in advanced robotics and embodied artificial intelligence systems. Industry data from Omdia indicates that China has surpassed the United States in humanoid robot manufacturing capacity and scalability, with Unitree and competitor AGIBOT each shipping over 5,000 units of the roughly 15,000 humanoid robots distributed globally in 2024.
Unitree generated approximately 1.7 billion yuan ($250 million) in revenue during 2025, derived primarily from sales of humanoid and quadruped robots, with international markets accounting for more than 40 percent of that total. The company cautioned that a July decision by the U.S. Federal Communications Commission to ban imports of new foreign-made humanoid and quadruped robots on national security grounds could limit its American market expansion, though existing models remain eligible for sale.
Despite their impressive market presence, analysts note that most humanoid robots remain confined to demonstrations, performances, and research applications rather than widespread industrial use. Morningstar analyst Kangyuxiao Li stated that “the real competitive test will be whether companies – Chinese or American – can achieve reliable performance and attractive returns on investment in large-scale industrial and commercial deployments.”
Unitree becomes the first publicly traded humanoid robotics manufacturer in mainland China, a milestone that could establish valuation benchmarks for comparable firms seeking listings. The company plans to allocate IPO proceeds toward advanced research and development initiatives and expansion of its manufacturing infrastructure.
More Stories
Ousted Ukrainian Defense Chief Demands Elections During Wartime, Citing Governance Breakdown
Nigeria’s Tinubu Launches Reelection Bid as Fragmented Opposition Prepares Challenge
Military Draft Exemptions for Ultra-Orthodox Jews Intensify Israeli Political Tensions